IRVINE, Calif., June 12, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. TARS, whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it will host a virtual event to provide an overview on…Read More
Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy Plans and Progress for TP03 Its Potential Treatment for Demodex Blepharitis Tarsus Pharmaceuticals NASDAQTARS
/cloudfront-us-east-1.images.arcpublishing.com/gray/6WTDTMHD55BWFONNBFOK3XEDAU.png)